Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Salon

Infectious anxiety disorder

Alan Cassels, Janne Leinonen and Teppo L.N. Järvinen
CMAJ June 10, 2014 186 (9) 720; DOI: https://doi.org/10.1503/cmaj.140352
Alan Cassels
Faculty of Human and Social Development, University of Victoria, Victoria, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janne Leinonen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teppo L.N. Järvinen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

At the risk of people worrying even more than they already do about their health, we propose adding a new diagnosis to the expanding collection of psychiatric diagnoses: infectious anxiety disorder (IAD). Concerned that a pandemic of anxiety is fast becoming a leading cause of global unhappiness, we propose that better research on IAD, an incredibly contagious form of anxiety, would help combat the worldwide spread of the disorder.

A key element in the early pathogenesis of IAD is concern about shrinking revenues within the “life-sciences” industry. After all, the world contains only a limited number of sick and solvent people, and cures are passé, providing only meager return on investment. The drive for profit is essential to the research-based company’s genetic code, and past strategies, which relied heavily on creating “me-toos” and expensive facelifts, are an unsustainable business model.

Faced with this enormous challenge, the life-sciences folks have the potential to develop an ingenious, and some would say foolproof, system: make health anxiety something that transmits well, infects others and spreads easily. By producing treatments not for the sick, but for those anxious about being sick, the life-sciences industry can create whole new markets for “healthy-people products,” a term coined by Henry Gadsden, former CEO of Merck.

Producing treatments for the “worried well” makes pharmacy cash registers ring; broadening diagnostic criteria and sprouting “prediseases” have made everyone — and their dogs — candidates for pharmacotherapy. What an incredible business model. In addition to inventing novel molecules to combat diseases, ingenious minds have discovered new diseases to precede them. The best diseases are the chronic ones that can be=diagnosed as early as possible (preferably in utero) and require daily, lifelong medication.

Figure
Image courtesy of Risto Nurisalo

Entanglements between doctors, specialists and patient advocates working with an evidence base that has been designed, published and promoted to meet shareholders’ needs have turned ordinary anxiety into an infectious pandemic. Physicians are hammered by clinical guidelines that sing the “underrecognized, underdiagnosed and undertreated” refrain. Is it any wonder docs themselves feel anxious and guilt-ridden? It doesn’t help that health-media scare stories fill our waiting rooms with anxious patients stoked by widespread “disease-awareness campaigns” and enough drug advertising to choke a horse.

Part of being a good parent is learning the art of distraction. If you keep kids occupied doing healthy things, then they won’t have time to do the unhealthy stuff. The drug industry knows this tactic well. That’s why it promotes the physician’s central role in diagnosing and treating prediseases. All the extra medical “busyness” leaves physicians with less leisure time to scrutinize the scientific evidence presented to them in prestigious journals.

Let’s not forget the lawyers and their role in spreading anxiety throughout medical communities, where even whispers of malpractice suits instill fear in anyone brave enough to veer away from clinical practice guidelines.

The time is ripe to tackle the silly promises of preventive pharmacotherapy and develop some immunity to IAD. For this, there’s no pill or vaccine, just good old skepticism. After all, physicians know that despite all the promises that come with preventive pills, most people still get old and sick (and bitter), especially when they learn that the much-publicized relative risk reduction did not apply to them.

Music too might work to banish the spread of IAD. We suggest the song “Don’t Worry, Be Happy” as the soundtrack to medicine’s drama. After all, being less anxious and more happy is a path many of us can choose, if we want to.

Do you have an opinion about this article? Post your views at www.cmaj.ca. Potential Salon contributors are welcome to send a query to salon{at}cmaj.ca.

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 186 (9)
CMAJ
Vol. 186, Issue 9
10 Jun 2014
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Infectious anxiety disorder
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Infectious anxiety disorder
Alan Cassels, Janne Leinonen, Teppo L.N. Järvinen
CMAJ Jun 2014, 186 (9) 720; DOI: 10.1503/cmaj.140352

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Infectious anxiety disorder
Alan Cassels, Janne Leinonen, Teppo L.N. Järvinen
CMAJ Jun 2014, 186 (9) 720; DOI: 10.1503/cmaj.140352
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The law and physician-assisted dying
  • Care, compassion, respect
  • Revisiting Rodriguez
Show more Salon

Similar Articles

Collections

  • Topics
    • Drugs: psychotherapeutic
    • Infectious diseases
    • Medical careers
    • Pharmacology & toxicology
    • Psychiatry & mental health: adult

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

CMA Civility, Accessibility, Privacy

 

Powered by HighWire